Literature DB >> 18794805

Phosphorylation by p38 MAP kinase is required for E2F1 degradation and keratinocyte differentiation.

I A Ivanova1, K-A Nakrieko, L Dagnino.   

Abstract

The transcription factor E2F1 plays key roles in skin homeostasis, and is essential for normal keratinocyte proliferation and epidermal regeneration after injury. We have previously established that, in differentiating keratinocytes, E2F1 activity is controlled by nuclear export and subsequent degradation. These events are triggered by differentiation-induced stimulation of protein kinase C and p38 mitogen-activated protein kinase (MAPK). However, the mechanisms that induce E2F1 export from the nucleus and the role of p38 MAPK in this process are poorly understood. We now describe a novel regulatory pathway for E2F1, which involves phosphorylation by p38. We demonstrate that E2F1 forms complexes with active p38 through regions that exclude the N-terminus of this transcription factor, and that p38 activity is a major contributor to the phosphorylation status of E2F1 in keratinocytes. Using in vitro kinase assays, we identified Ser403 and Thr433 as the residues phosphorylated by p38. The biological significance of these observations is underscored by the inability of E2F1 mutants lacking one or both of these residues to be exported from the nucleus and degraded when keratinocytes receive differentiation stimuli, which results in impaired keratinocyte maturation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18794805     DOI: 10.1038/onc.2008.354

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 transcription factor-mediated control of cyclin transcription.

Authors:  Jessy Cartier; Jean Berthelet; Arthur Marivin; Simon Gemble; Valérie Edmond; Stéphanie Plenchette; Brice Lagrange; Arlette Hammann; Alban Dupoux; Laurent Delva; Béatrice Eymin; Eric Solary; Laurence Dubrez
Journal:  J Biol Chem       Date:  2011-06-08       Impact factor: 5.157

2.  An IKKα-E2F1-BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence.

Authors:  Massimo Ammirante; Ali I Kuraishy; Shabnam Shalapour; Amy Strasner; Claudia Ramirez-Sanchez; Weizhou Zhang; Ahmed Shabaik; Michael Karin
Journal:  Genes Dev       Date:  2013-06-24       Impact factor: 11.361

3.  Down-regulation of IL-6, IL-8, TNF-α and IL-1β by glucosamine in HaCaT cells, but not in the presence of TNF-α

Authors:  Kun Park; Ji-Hye Lee; Ho-Chan Cho; Sun-Young Cho; Jae-We Cho
Journal:  Oncol Lett       Date:  2010-03-01       Impact factor: 2.967

4.  RORα binds to E2F1 to inhibit cell proliferation and regulate mammary gland branching morphogenesis.

Authors:  Gaofeng Xiong; Ren Xu
Journal:  Mol Cell Biol       Date:  2014-06-02       Impact factor: 4.272

5.  The p38 MAPK-MK2 axis regulates E2F1 and FOXM1 expression after epirubicin treatment.

Authors:  Natalia de Olano; Chuay-Yeng Koo; Lara J Monteiro; Paola H Pinto; Ana R Gomes; Rosa Aligue; Eric W-F Lam
Journal:  Mol Cancer Res       Date:  2012-07-16       Impact factor: 5.852

6.  E2F1 regulates cellular growth by mTORC1 signaling.

Authors:  Sebastian Real; Nathalie Meo-Evoli; Lilia Espada; Albert Tauler
Journal:  PLoS One       Date:  2011-01-24       Impact factor: 3.240

7.  Shape-induced terminal differentiation of human epidermal stem cells requires p38 and is regulated by histone acetylation.

Authors:  John T Connelly; Ajay Mishra; Julien E Gautrot; Fiona M Watt
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

Review 8.  Regulation of E2F1 Transcription Factor by Ubiquitin Conjugation.

Authors:  Laurence Dubrez
Journal:  Int J Mol Sci       Date:  2017-10-19       Impact factor: 5.923

9.  EGFR Induces E2F1-Mediated Corticotroph Tumorigenesis.

Authors:  Takako Araki; Xiaohai Liu; Hiraku Kameda; Yukiko Tone; Hidenori Fukuoka; Masahide Tone; Shlomo Melmed
Journal:  J Endocr Soc       Date:  2017-01-20

10.  E2F1 interactions with hHR23A inhibit its degradation and promote DNA repair.

Authors:  Randeep K Singh; Lina Dagnino
Journal:  Oncotarget       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.